BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 8635527)

  • 1. In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation.
    Watanabe T; Brown GS; Kelsey LS; Yan Y; Jackson JD; Ewel C; Kessinger A; Talmadge JE
    Exp Hematol; 1996 May; 24(6):713-21. PubMed ID: 8635527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
    Jackson JD; Yan Y; Ewel C; Talmadge JE
    Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo haemoprotective activity of tetrapeptide AcSDKP combined with granulocyte-colony stimulating factor following sublethal irradiation.
    Watanabe T; Kelsey LS; Yan Y; Brown GS; Jackson JD; Ewel C; Talmadge JE
    Br J Haematol; 1996 Sep; 94(4):619-27. PubMed ID: 8826883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
    Patchen ML; Fischer R; MacVittie TJ
    Exp Hematol; 1993 Feb; 21(2):338-44. PubMed ID: 7678816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible inhibitory effects and absence of toxicity of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in human long-term bone marrow culture.
    Bonnet D; Lemoine FM; Khoury E; Pradelles P; Najman A; Guigon M
    Exp Hematol; 1992 Nov; 20(10):1165-9. PubMed ID: 1385195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
    van Os R; Robinson S; Sheridan T; Mauch PM
    Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced engraftment of intravenously transplanted hematopoietic stem cells into bone marrow of irradiated mice treated with AcSDKP.
    Suzuki A; Aizawa S; Araki S; Hoshi H; Nakano M; Kimura Y; Toyama K
    Exp Hematol; 1998 Jan; 26(1):79-83. PubMed ID: 9430517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hematopoiesis in long-term marrow cultures established on adherent layers from AcSDKP-treated dogs.
    Hong DS; Graham T; Ewel C; Storb R; Deeg HJ
    Exp Hematol; 1995 Jul; 23(7):639-44. PubMed ID: 7601256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Galactosylceramide (AGL-517) treatment protects mice from lethal irradiation.
    Inoue H; Koezuka Y; Nishi N; Osawa M; Motoki K; Kobayashi E; Kabaya K; Obuchi M; Fukushima H; Mori KJ
    Exp Hematol; 1997 Aug; 25(9):935-44. PubMed ID: 9257806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The hemoprotective effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP].
    Han Z; Cai Y; Aidoudi S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):33-5. PubMed ID: 11498842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoprotection of normal human hematopoietic progenitors by the tetrapeptide N-AcSDKP.
    Coutton C; Guigon M; Bohbot A; Ferrani K; Oberling F
    Exp Hematol; 1994 Oct; 22(11):1076-80. PubMed ID: 7925774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.
    Laterveer L; Zijlmans JM; Lindley IJ; Hamilton MS; Willemze R; Fibbe WE
    Exp Hematol; 1996 Oct; 24(12):1387-93. PubMed ID: 8913284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K; Vos B; Kang-Er Z; Guiffre A; Seymour R; Gillis S
    Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression.
    Kovacs CJ; Kerr JA; Daly BM; Evans MJ; Johnke RM
    Anticancer Res; 1998; 18(3A):1805-12. PubMed ID: 9673408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transplantation of mesenchymal derived stem cells followed by G-CSF injection can reconstitute hematopoiesis of lethally irradiated BALB/c mice].
    Hu Y; Ma L; Ma GJ; Jiang XY; Zhao CH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):20-4. PubMed ID: 12905834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
    Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
    Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with granulocyte colony-stimulating factor reduces myelopoiesis in irradiated mice.
    Pospísil M; Hofer M; Netíková J; Holá J; Znojil V; Vácha J; Vacek A
    Radiat Res; 1999 Mar; 151(3):363-7. PubMed ID: 10073675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival enhancement and hemopoietic regeneration following radiation exposure: therapeutic approach using glucan and granulocyte colony-stimulating factor.
    Patchen ML; MacVittie TJ; Solberg BD; Souza LM
    Exp Hematol; 1990 Oct; 18(9):1042-8. PubMed ID: 1697806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.